COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

Zixin Pharmaceutical was invited to participate in the ninth plenary meeting of the International Organization for Standardizati

Page view

From June 4 to 7, 2018, the ninth plenary meeting of the International Organization for Standardization/Traditional Chinese Medicine Technical Committee (ISO/TC249) was held in Shanghai International Guidu Hotel. Zixin Pharmaceutical was invited as an expert representative. This is the fifth time that Zixin Pharmaceutical has participated in the third plenary meeting of ISO/TC249 in 2012.

The meeting was hosted by the National Standardization Administration Committee and the State Administration of Traditional Chinese Medicine, and was hosted by the China Academy of Chinese Medical Sciences and Shanghai University of Traditional Chinese Medicine. Xu Kunlin, deputy mayor of Shanghai Municipal People's Government, Chen Hongjun, deputy director of the National Standardization Administration Committee, David Graham, chairman of ISO/TC249, Xu Jianguang, president of Shanghai University of Traditional Chinese Medicine, Yang Longhui, vice president of China Academy of Chinese Medical Sciences, and Ma Jianzhong, deputy director of the State Administration of Traditional Chinese Medicine attended the opening ceremony. And a speech.

14 members from China, Japan, South Korea, the United States, Germany, Australia, Thailand, Saudi Arabia, etc. participated in the conference, World Health Organization (WHO), International Organization for Standardization / Health Information Technology Committee (ISO/TC215), the world The Federation of Chinese Medicine Societies (WFCMS) and the World Federation of Acupuncture Associations (WFAS) attended the conference as a liaison organization, with 226 delegates attending the conference.

 

ISO/TC249 was established in 2009, and the number of participants and standard proposals has increased year by year, effectively promoting the internationalization of China's traditional Chinese medicine industry. It is reported that ISO/TC249 has officially released 28 international standards for Chinese medicine, and 46 international standards are being formulated, achieving a major breakthrough in the international standard of Chinese medicine in the ISO field. As an outstanding representative of traditional medicine, traditional Chinese medicine plays an important role in safeguarding the health of human beings all over the world. The establishment and development of ISO/TC249 has far-reaching influence on the promotion of international trade of Chinese medicine and the internationalization of Chinese medicine. The convening of the ninth plenary session of ISO/TC249 has provided a wide range of in-depth communication and cooperation between Chinese experts and Chinese medicine practitioners around the world. platform.

The conference received a total of 33 new proposals from China, South Korea and the World Federation of Chinese Medicine Societies. Guo Chunsheng, the actual controller of Zixin Pharmaceutical, and Xu Dehui, the vice president of R&D, led the company's many Chinese medicine experts to participate in the conference as experts of the project team, and participated in the report discussion of many proposals on ginseng and American ginseng. During the period, Zixin Participating Group and other national experts worked together to promote consensus, seek common ground while reserving differences, and develop together, and contribute wisdom to research and develop high-quality ISO Chinese medicine standards and promote the sustainable development of traditional Chinese medicine and traditional medicines of various countries.

 

Zixin Pharmaceutical, which adheres to and adheres to the principle of “Strengthening China's Power for International Discourse and Promoting the Development of National Industry”, has been actively participating in the formulation of ginseng standardization at different levels, such as international, national, industry and local, for many years. Participated in the formulation of 4 local standards for ginseng food in Jilin Province, 38 enterprise standards, and participated in the formulation of 4 ginseng health food enterprise standards. Zixin Pharmaceutical has made outstanding contributions to the deep cultivation, processing and sales of ginseng, which has effectively promoted the ISO/TC249 international standards for ginseng and the development of international standards for Chinese medicine, and provided demonstrations for the development of international standards for other Chinese medicinal herbs.

In 2012, Zixin Pharmaceutical participated in the third plenary meeting of ISO/TC249 and actively participated in the development of the international standard for ISO "Chinese medicine - ginseng seed seedlings - the first part: Asian ginseng", which was in 2014. It was released by ISO in the first half of the year and became one of the first international standards for Chinese medicine published by ISO. In May 2014, Zixin Pharmaceutical participated in the fifth plenary meeting of ISO/TC249 and actively participated in the formulation of the requirements of the production process of red ginseng industry.

 

In August 2014, the Chinese Medicine Resource Center of the China Academy of Chinese Medical Sciences teamed up with 6 family members and nearly 10 research institutes to form the “Ginseng International Standard Technology Alliance” and actively participated in the research and formulation of ginseng international standards. The first executive director unit and assume the work of the alliance secretariat. In 2015, Zixin Pharmaceuticals established the secretariat of the International Standards and Technology Alliance of Ginseng, located in Beijing, and actively carried out various related work.

From June 1st to 4th, 2015, the sixth plenary meeting of ISO/TC249 was held in Beijing, and the scale of the meeting was the highest in the calendar year. At this meeting, Zixin Pharmaceutical was the only authorized support unit of the conference from the past participating enterprises. At the same time, the contribution of Zixin Pharmaceutical in the standardization of Chinese medicine was written into the 203 resolutions of the conference, which became the most dazzling of the conference. The "star".

 

In view of the outstanding contribution of Zixin Pharmaceutical in the international standard of ginseng and the development of international standards for Chinese medicine, in 2107, Zixin Pharmaceutical became the only authorized support unit of the eighth plenary meeting of ISO/TC249.

 

In the future, Zixin Pharmaceutical will further support the work of the international standardization platform for Chinese medicine and the training of international standardization talents for Chinese medicine, vigorously carry out international standardization cooperation and exchanges of Chinese medicine, and enable the international standardization of Chinese medicine to serve the implementation of the “One Belt, One Road” national strategy. The international standardization of Chinese medicine has made more contributions to global economic development and human health!